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Helicobacter pylori is recognized as an important human pathogen
that causes chronic gastritis and is associated with gastric atrophy
which can lead to adenocarcinoma and MALT lymphoma of
the stomach [1,2]. The establishment of the H. pylori infection
in the stomach depends on several host and bacterial factors [1].
The expression of specific host antigens such as Lewis-type
blood group antigen, may play an important role [3,4]. Helico-
bacter pylori itself secretes several enzymes, such as urease, which,
by neutralizing the acidic pH of the stomach allows the organ-
ism to survive [1].
Among the most important bacterial factors in the patho-
genesis are the CagA protein and the VacA cytotoxin. The
presence of CagA is associated with duodenal ulceration, gastric
mucosal atrophy and gastric cancer [5]. Another attribute is the
cytotoxin that induces the formation of vacuoles in mammalian
cells in vitro leading to cell death [6]. This toxin is encoded by
the vacA gene which appears to be highly diverse, and recently
the existence of a different allelic variant in the second segment
of this gene has been described [7,8].
The serum antibody response could provide important infor-
mation regarding the severity of H. pylori-associated disease.
Several studies have demonstrated a strong correlation between
the level of anti-H. pylori immunoglobulin (Ig)G antibodies
and the colonization of the gastric mucosa by bacteria [1,9].
However, the H. pylori IgG antibody patterns have been
reported to show a high degree of diversity [10,11]. Xiang et al.
[12] described an enzyme immune assay (EIA) with recom-
binant antigen including a fragment of the CagA protein. They
concluded that there is a positive correlation between EIA and
Western blotting methods used to detect anti-CagA antibodies.
They have also shown a strong correlation between CagA
antibody level and the presence of an ulcer. Other studies have
found that Western blot is even more sensitive as well as more
specific than EIA [11,12]. However, other antibodies or com-
binations of antibodies may also be useful as markers of the
severity of the disease.
The present study was undertaken to determine the preva-
lence of antibodies to Cag A, and VacA in our patients, and
also to study whether the infection with an H. pylori strain
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expressing the vacA and/or the cagA is associated with severe
disease outcome in our Bahraini patient population.
A total of 57 consecutive patients examined in the Gastro-
Enterology Clinics in Bahrain, were enrolled in the study
between 1997 and 1998. The patients presented with dyspeptic
syndromes and underwent an upper gastroduodenal endoscopy.
All the patients were seropositive by total IgG EIA (Meddens
Diagnostics B V, Vorden, The Netherlands). They had received
no antimicrobial therapy during the previous 2 months. Sera
were collected on the day of the endoscopy; they were ali-
quoted and frozen at 80 °C until they were used.
The CagA and VacA antibodies were determined by com-
mercially available kits, the RIDA Blot Helicobacter (R
Biopharm GmbH, Hamburg, Germany), a qualitative in vitro
immunoblot test for the detection of specific antibodies (IgA,
IgG) against Helicobacter pylori in human serum and plasma, were
used in this study.
Samples were evaluated by using evaluation strip template
(coated with antigen bands of H. pylori) lined with sample
bands. These bands received point values which are determined
depending on the meaning of the bands and their detected
immunoglobulin class. The results of IgG and IgA were classi-
fied as positive, questionable or negative according to the manu-
facturer’s recommendations.
The chi-square test was employed to evaluate the results by
using a statistical analysis program (SPSS Microsoft 7.5 for
windows). The level of significance was established for P-values
0.005.
All 57 patients underwent gastroscopy. Twenty-eight (49%)
were suffering from moderate to severe gastritis, seven (12%)
had duodenal ulcer, four 4 (7%) had duodenitis and 18 (31%)
were normal by endoscopy.
The analysis of patients serum by immune blot using the kit
scoring systems showed that 47 (82%) of our patients were
positive for IgG, nine (15%) were negative and one (3%) ques-
tionable. Only 26 (45%) were positive with the IgA test, 25
(45%) were negative and six (10%) questionable (Table 1).
From these results one can clearly conclude that the number of
positive H. pylori cases were significantly more reactive with
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Table 1 Total Immunoblot results of IgG and IgA tests
Results IgG Test IgA Test
No. of cases (%) No. of cases (%)
Positive 47 82 26 45
Not known 1 1.7 6 10.5
Negative 9 15 25 43.8
the IgG test than with the IgA test with a mean rank of 15.02
and a significance rate of P  0.001.
A total of 57 blots of patients’ serum were analysed: the
blots revealed from 1 to 15 bands with an average of 7.2 bands
for the IgG tests and 1 to 7 bands with an average of 1.9 bands
for IgA. The blots were analysed by more than one investigator.
Fifteen different bands were distinguished on the 57 blots.
A high percentage of our patients’ sera were reactive to the
29 and 28 kDa bands; 45 (78%) and 46 (80%), respectively.
We analysed the blots for the presence of CagA, and VacA
antibodies. Thirty-two (56%) of our patients developed IgG
antibodies to CagA and VacA. One developed antibodies to
CagA only, three to VacA only and 21 patients did not develop
antibodies to either.
Twenty-two (78.5%) patients with gastritis were positive
for CagA and 23 (82.1%) were positive for VacA antibodies,
compared with only five (27.7%) and six (33.3%), respectively,
of the subjects with normal endoscopy (P  0.005). The seven
patients with duodenal ulcer were positive for both CagA and
VacA antibodies.
Several methods for laboratory diagnosis of H. pylori have
been described, which fall within two categories. The bac-
teriological (culture method) is unquestionably the most speci-
fic, but it is subject to sample errors and not very sensitive. The
other category is the breath test and serology; they are more
sensitive, but they may be less specific. Serology is now con-
sidered to be a global method of diagnosis with a variety of
commercially available kits, most of them providing satisfactory
reactions [1,9,13,14]. However significant improvement must
be made before it can be considered as a reference method.
Our data are in agreement with other studies [15,16] with
regard to the importance of IgG in the immunodiagnosis of H.
pylori infection when compared to IgA. This may be due to the
fact that IgA antibodies may appear earlier than IgG during the
infection period and disappear after a short time (short half life)
[17] whereas IgG antibodies may persist for a long time in the
serum.
In our study we found four antigens 120, 87, 29, 28 kDa to
be the most immunogenic during H. pylori infection in our
patient population, which is consistent with other studies [11].
However a large number of our patients’ sera (78%) were
reactive to the 29 kDa band (urease A), and 80% were reactive
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to an unknown 28 kDa band. The reason for this high per-
centage needs to be investigated.
Helicobacter pylori infection leads to a variety of diseases. At
present the only reliable way to identify the association of H.
pylori with the illness remains endoscopy in combination with
histological examination of the gastric mucosa. Large numbers
of studies were conducted to correlate the severity of the H.
pylori infection to the antibody level, specificity and type [2,18–
21]. In our patient population we found that both anti-Cag A,
and -VacA existed more frequently in patients with gastritis and
duodenal ulcer, which is also consistent with the above studies.
Eighteen (31%) of our patients were normal by endoscopy,
despite being positive by total IgG EIA. This could be due to
the fact that peptic ulcer or gastritis may be intermittent and
some patients may be non-ulcerous at the time of endoscopy.
An elevated proportion of the sera from symptomatic Bah-
rain patients showed IgG antibodies against CagA and VacA
antigens. This proportion was higher among patients with gas-
tritis or ulcer disease in comparison with the subjects with
normal endoscopy. Immunoblot would be useful for screening
patients at risk of ulcer or even before starting therapy.
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Oropharyngeal candidiasis (OPC) that is refractory to therapy
with fluconazole has been increasingly reported in HIV-
infected patients after long-term use of fluconazole [1].
Recently, a patient was reported in whom fluconazole-refrac-
tory mucosal candidiasis resolved after the initiation of treat-
ment with an antiretroviral agent combined with a protease
inhibitor [2]. It was argued that improving immune function
was responsible for this effect, but information about the Can-
dida strains was not given. In this report, we describe a patient
who suffered from fluconazole-refractory oral and esophageal
candidiasis (OC) but resolved this disease after a change in
antifungal therapy as well as initiation of highly active anti-
retroviral therapy (HAART), together with clearance of the
fluconazole-resistant C. albicans strain.
A 37-year-old homosexual man with HIV infection diag-
nosed in 1993 presented in March 1996 with a gastric lym-
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phoma and OC. The CD4 count was 2/mL, and the HIV load
was 32  103 copies RNA/mL. He had a history of recurrent
OPC since 1994 and had received daily treatment with flu-
conazole 200–400 mg/day for the past 2 years. The Epstein–
Barr virus-associated lymphoma in the stomach was treated
with chemotherapy and resolved in May 1996. During this
period, OPC and OC persisted despite administration of flu-
conazole (200–400 mg/day) and amphotericin B oral sus-
pension (12 mL/day). In November 1996, intravenous therapy
with Ambisome (5 mg/kg/day) was given and candidiasis
resolved temporarily, but reoccurred rapidly under secondary
prophylaxis with Ambisome (5 mg/kg/day) given once-weekly
in January 1997. Antiretroviral therapy was changed from single
therapy with saquinavir in November 1996 to triple therapy
(HAART) with zidovudine (250 mg twice-daily), lamivudine
(150 mg twice-daily) and saquinavir (600 mg thrice-daily). Due
